Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Contraception |
Dose: Tablet – 1 hormonally active tablet Frequency: once daily Duration: 21 days, then 7 inert (iron) tablets; repeat cycle Note: Start on day 1 of menstrual cycle; administered by mouth |
|
Indication: Initiating after Pregnancy Condition: After vaginal birth |
Dose: Tablet – 1 hormonally active tablet Note: Wait at least 3 weeks before initiating; Women with other risk factors for VTE in addition to postpartum: Do not use combined hormonal contraceptives |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prevention of pregnancy Age: Post-menarchal females |
Dose: Tablet – 1 tablet Frequency: Once daily Note: By mouth (oral) |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment |
Dose: Not mentioned Note: Use caution; monitor blood pressure |
Administration
- Take with vitamin C-rich foods
- Take at same time daily
Side Effect
- Edema
- Weakness
- Amenorrhea
- Breakthrough bleeding
- Change in menstrual flow
- Spotting
- Anorexia
- DVT
- Thrombophlebitis
- Depression
- Dizziness
- Headache
- Nervousness
- Somnolence
- Breast tenderness
- Galactorrhea
- Abdominal pain
- Nausea
- Vomiting
- Change in weight
- Cholestatic jaundice
- Hepatic tumours
- increased risk of thromboembolism
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Antibiotics, Anticonvulsants (Phenytoin, Carbamazepine, Valproic acid, Lamotrigine, Levetiracetam, Topiramate), Bosentan, Rifampicin, Rifabutin, Barbiturates, Primidone, Phenytoin, Carbamazepine, Oxcarbazepine, Topiramate, Griseofulvin, Aprepitant
|
Reduced contraceptive effectiveness
|
|
Troleandomycin
|
Severe pruritus and jaundice
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Undiagnosed Vaginal Bleeding
|
Can mask serious conditions
|
|
Severe Arterial Disease
|
Risk of blood clots
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30°C, protected from light & moisture. Keep all medicines out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.